NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OxSonics Therapeutics

OxSonics Therapeutics

Private
OxfordHealthcare & Life Scienceshttps://oxsonics.com/

Last Round

Series B

Extension

Jul 1, 2020

Total Funding Raised

$25.48M

Company Overview

OxSonics Therapeutics is a clinical-stage medtech company that develops ultrasound-based drug delivery platforms to enhance the efficacy of oncology treatments for solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

ultrasound drug deliverysolid tumor treatmentSonoTrandrug delivery platformacoustic cavitationpassive acoustic mappingoncology devicemedtechmedical ultrasounddrug penetrationtherapeutic agent deliverybiotechcancer therapysee-as-you-treat

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OxSonics Therapeutics Comps

Public and private peers based on sector, stage, and business model.

OxSonics Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OxSonics Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJul 1, 2020
SeedJan 1, 2014

OxSonics Therapeutics Investors

Notable investors and investment history

OxSonics Therapeutics investors
InvestorRounds
Perivoli InnovationsSeries B Extension
Oxford University InnovationSeries B, Seed
MMK CapitalSeries B Extension
Oxford Technology and Innovations EIS FundSeries B Extension
Longwall Venture PartnersSeries B Extension, Series B, Seed
National Institute for Health and Care ResearchGrant

OxSonics Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OxSonics Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OxSonics Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersOxford
Employee Range15
Year Founded2013
Last FundingJul 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.